Associate Professor, Pathology and Laboratory Medicine, Hofstra North Shore-LIJ School of Medicine

Pathology

Sharon Liang works in the field of Pathology. She researched medicine at Hunan Medical University. Sharon X. Liang, MD is a published physician as well. She has 37 publications published. The latest was: Assessment of the Utility of PAX8 Immunohistochemical Stain in Diagnosing Endocervical Glandular Lesions. She accepts Medicare.

Publications

---

• Assessment of the Utility of PAX8 Immunohistochemical Stain in Diagnosing Endocervical Glandular Lesions.
• Geographical variations of risk factors associated with HCV infection in drug users in southwestern China.
• Primary Myxoid Liposarcoma of the Ovary in a Postpartum Female: A Case Report and Review of Literature.
• Measurement of prompt ψ(2S) to J/ψ yield ratios in Pb-Pb and p-p collisions at sqrt[sNN]=2.76  TeV.
• Evidence of b-Jet Quenching in PbPb Collisions at sqrt[s_{NN}]=2.76  TeV.
• Risk Factors for GI Adverse Events in a Phase III Randomized Trial of Bevacizumab in First-Line Therapy of Advanced Ovarian Cancer: A Gynecologic Oncology Group Study.
• Circulating biomarkers for detection of ovarian cancer and predicting cancer outcomes.
• Utility of α-methylacyl-coenzyme-A racemase (p504s) immunohistochemistry in distinguishing endometrial clear cell carcinomas from serous and endometrioid carcinomas.
• Frequent Expression of Napsin A in Clear Cell Carcinoma of the Endometrium: Potential Diagnostic Utility.
• Patient reported outcomes of a randomized, placebo-controlled trial of bevacizumab in the front-line treatment of ovarian cancer: a Gynecologic Oncology Group Study.
• The clinicopathologic significance of p53 and BAF-250a (ARID1A) expression in clear cell carcinoma of the endometrium.
• Expression of the oncofetal protein IGF2BP3 in endometrial clear cell carcinoma: assessment of frequency and significance.
• Morphologic and other clinicopathologic features of endometrial clear cell carcinoma: a comprehensive analysis of 50 rigorously classified cases.
• Expression of tissue factor and heparanase in endometrial clear cell carcinoma: possible role for tissue factor in thromboembolic events.
• The phosphatidylinositol 3' kinase-Akt-mammalian target of rapamycin pathway in smooth muscle tumors of the uterus: selected protein expression patterns and their clin...
• Personal history of breast cancer as a significant risk factor for endometrial serous carcinoma in women aged 55 years old or younger.
• Patterns of Bone Morphogenetic Protein-2 Expression in Smooth Muscle Tumors of the Uterine Corpus and Other Uterine Tissues.
• Molecular identification of "latent precancers" for endometrial serous carcinoma in benign-appearing endometrium.
• Epithelioid smooth muscle tumors of the uterus do not express CD1a: a potential immunohistochemical adjunct in their distinction from uterine perivascular epithelioid ...
• A comparative analysis of lymphatic vessel density in ovarian serous tumors of low malignant potential (borderline tumors) with and without lymph node involvement.
• The oncofetal protein IMP3: a novel biomarker for endometrial serous carcinoma.
• "Malignant" uterine perivascular epithelioid cell tumor, pelvic lymph node lymphangioleiomyomatosis, and gynecological pecomatosis in a patient with tuberous...
• Variations of mitotic index in normal and dysplastic squamous epithelium of the uterine cervix as a function of endometrial maturation.
• Sertoliform endometrioid carcinoma of the endometrium with dual immunophenotypes for epithelial membrane antigen and inhibin alpha: case report and literature review.
• Carcinomas of ovary and lung with clear cell features: can immunohistochemistry help in differential diagnosis?
• Occurrence of endometrial glandular dysplasia precedes uterine papillary serous carcinoma.
• Precursors of endometrial clear cell carcinoma.
• Initial endometriosis showing direct morphologic evidence of metaplasia in the pathogenesis of ovarian endometriosis.
• Endometrial glandular dysplasia: a putative precursor lesion of uterine papillary serous carcinoma. Part II: molecular features.
• Endometrial glandular dysplasia: a newly defined precursor lesion of uterine papillary serous carcinoma. Part I: morphologic features.
• Household transmissibility of avian influenza A (H7N9) virus, China, February to May 2013 and October 2013 to March 2014.
• Notch ligand-dependent gene expression in human endometrial stromal cells.
• CD44 expression is a feature of prostatic small cell carcinoma and distinguishes it from its mimickers.
• Vulvar varices: an uncommon entity in surgical pathology.
• A high-grade uterine leiomyosarcoma with human chorionic gonadotropin production.
• Incorporation of bevacizumab in the primary treatment of ovarian cancer.

Schools

---

• Hunan Normal University College Of Medicine

• University Mass Med School

• Yale University School Of Med

Doctors Specialties

---

• Pathology

Accepted Insurances

---

Education

---

• Yale-New Haven Hospital
• University of Massachusetts
• Hunan Medical University

Hospital

---

• Huntington Hospital
• Long Island Jewish Medical Center
• Plainview Hospital
• Southside Hospital

Helpful Reviews

---

Give Anonymous Review

Medicare Facts

---

National Provider Identifier [NPI]	1851334726
Last Name Of The Provider	LIANG
First Name Of The Provider	SHARON
View All

Similar Doctors

---

	Dr. Bryan E. Harmon, MD This Doctor is OpenDoctor Recommended.
	Dr. Meenakshi Singh, MD This Doctor is OpenDoctor Recommended.
	Dr. Ute M. Moll, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Sergey Lyubsky, MD This Doctor is OpenDoctor Recommended.
	Dr. Alan Heimann, MD This Doctor is OpenDoctor Recommended.
	Dr. Carmen S. Tornos, MD This Doctor is OpenDoctor Recommended.

---

Doctor Directory | TOS | twitter | FB | Angel | blog